Company page

Cytosorbents Corporation

Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $22.6 million. The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.